These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11431201)

  • 21. Distribution of HCV genotypes in patients with end-stage renal disease according to type of dialysis treatment.
    Selcuk H; Kanbay M; Korkmaz M; Gur G; Akcay A; Arslan H; Ozdemir N; Yilmaz U; Boyacioglu S
    Dig Dis Sci; 2006 Aug; 51(8):1420-5. PubMed ID: 16868830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
    Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
    Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus (HCV) infection in haemodialysed patients: HCV-RNA and anti-HCV antibodies (third-generation assays).
    Couroucé AM; Bouchardeau F; Chauveau P; Le Marrec N; Girault A; Zins B; Naret C; Poignet JL
    Nephrol Dial Transplant; 1995; 10(2):234-9. PubMed ID: 7538650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occult hepatitis C virus infection among haemodialysis patients.
    Ali NK; Mohamed RR; Saleh BE; Alkady MM; Farag ES
    Arab J Gastroenterol; 2018 Sep; 19(3):101-105. PubMed ID: 30245116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of polymerase chain reaction assays for the detection of hepatitis C virus infection in a hemodialysis unit.
    Hussein MM; Mooij JM; Hegazy MS; Bamaga MS
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):107-13. PubMed ID: 17237902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic variability of hepatitis C virus in dialysis: the implications.
    Fabrizi F; Lunghi G; Poordad FF; Martin P
    Int J Artif Organs; 2002 Nov; 25(11):1034-48. PubMed ID: 12487391
    [No Abstract]   [Full Text] [Related]  

  • 27. [Viral hepatitis C in patients with terminal chronic renal insufficiency. III. Viral quantification].
    González-Michaca L; Soto-Ramírez LE; Rodríguez R; Gamba G
    Rev Invest Clin; 2001; 53(1):21-7. PubMed ID: 11332047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C--the virus as well as the antibody.
    Sweeting J
    Gastroenterology; 1991 Apr; 100(4):1144-5. PubMed ID: 1848197
    [No Abstract]   [Full Text] [Related]  

  • 29. Virological characteristics of hepatitis C virus infection in chronic hemodialysis patients: a cross-sectional study.
    Fabrizi F; Lunghi G; Guarnori I; Raffaele L; Di Filippo S; Erba G; Pagano A; Locatelli F
    Clin Nephrol; 1995 Jul; 44(1):49-55. PubMed ID: 7554533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A twelve year natural history of hepatitis C virus infection in hemodialyzed patients.
    Simon N; Couroucé AM; Lemarrec N; Trépo C; Ducamp S
    Kidney Int; 1994 Aug; 46(2):504-11. PubMed ID: 7967364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maintenance hemodialysis decreases serum hepatitis C virus (HCV) RNA levels in hemodialysis patients with chronic HCV infection.
    Furusyo N; Hayashi J; Ariyama I; Sawayama Y; Etoh Y; Shigematsu M; Kashiwagi S
    Am J Gastroenterol; 2000 Feb; 95(2):490-6. PubMed ID: 10685756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a minipool reverse transcription-PCR screening method for the detection of hepatitis C virus infection in hemodialysis patients.
    Garinis G; Patrinos GP; Menounos P; Spanakis N; Gorgoulis VG; Theodorou V; Ioannidis T; Karameris A; Valis D
    Clin Chem; 2000 Apr; 46(4):583-4. PubMed ID: 10759488
    [No Abstract]   [Full Text] [Related]  

  • 33. Viral clearance or persistence after acute hepatitis C infection: interim results from a prospective study.
    Guobuzaite A; Chokshi S; Balciūniene L; Voinic A; Stikleryte A; Zagminas K; Ambrozaitis A; Naoumov N
    Medicina (Kaunas); 2008; 44(7):510-20. PubMed ID: 18695347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acquisition of hepatitis C virus in hemodialysis patients: a prospective study by branched DNA signal amplification assay.
    Fabrizi F; Martin P; Dixit V; Brezina M; Cole MJ; Gerosa S; Mousa M; Gitnick G
    Am J Kidney Dis; 1998 Apr; 31(4):647-54. PubMed ID: 9531181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HCV-RNA Pcr Positivity In Hcv Antibody Negative Patients Undergoing Haemodialysis.
    Kiani IG; Khan AN; Butt B; Sabir S; Ejaz S; Perveen A; Ghani E
    J Ayub Med Coll Abbottabad; 2018; 30(3):397-400. PubMed ID: 30465373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of routine real time quantitative PCR monitoring of HCV infection in haemodialysis patients.
    Datta S; Goel N; Wattal C
    Indian J Med Microbiol; 2015 Feb; 33 Suppl():106-11. PubMed ID: 25657124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Summaries for patients. Liver disease in persons with asymptomatic hepatitis C virus infection.
    Ann Intern Med; 2002 Dec; 137(12):I36. PubMed ID: 12484740
    [No Abstract]   [Full Text] [Related]  

  • 38. Hemodialysis access surgery--is there an increased risk of acquiring hepatitis C virus compared to other elective vascular interventions?
    Assadian A; Assadian O; Holak G; Watkins-Riedel T; Senekowitsch C; Kovarik J; Hagmüller GW
    Vasa; 2008 Feb; 37(1):81-5. PubMed ID: 18512545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members].
    Miyasaka M
    Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HBV-DNA in hemodialysis patients infected by HCV.
    Arababadi MK; Hassanshahi G; Yousefi H
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):398-401. PubMed ID: 19414941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.